Business, Health Care, Science

Fonseca Biosciences secures exclusive US rights to XTORO® (finafloxacin otic suspension) 0.3 percent to treat ‘swimmer’s ear’

XTORO is a new chemical entity that is FDA approved for the treatment of acute otitis externa, commonly known as “swimmer’s ear,” caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus LONG BEACH TOWNSHIP, N.J. — (BUSINESS WIRE) — Fonseca Biosciences

Business, Environment, Science

Veolia joins WFX Water Roundtable to improve water infrastructure and bring water equity to underserved American communities  

 Water Roundtable creates new opportunities for Veolia to support American communities facing health and environmental threats from substandard water and wastewater infrastructure    Veolia commits financial, technical and operational support to water technology improvements and creates pathway for employees to volunteer to

Business

inTEST Corporation to participate in the 13th Annual NYC Summit

MT. LAUREL, N.J. — (BUSINESS WIRE) — inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor